Immunome Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Immunome Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Immunome Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.89M, a 352% increase year-over-year.
  • Immunome Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $13.2M, a 180% increase year-over-year.
  • Immunome Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.22M, a 16.7% increase from 2022.
  • Immunome Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.33M, a 54.6% increase from 2021.
  • Immunome Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.45M, a 455% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.22M +$891K +16.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $5.33M +$1.88M +54.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $3.45M +$2.83M +455% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $621K +$607K +4336% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $14K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.